San Diego-based Digirad is putting the finishing touches in place for a commercial launch of its solid-state digital gamma camera technology. The firm is taking orders for its lead product, Digirad 2020 TC Imager, and plans to begin commercial shipments
San Diego-based Digirad is putting the finishing touches in place for a commercial launch of its solid-state digital gamma camera technology. The firm is taking orders for its lead product, Digirad 2020 TC Imager, and plans to begin commercial shipments as soon as it completes work on a manufacturing facility to build the cameras.
Digirad received 510(k) clearance last year for 2020 TC Imager, which uses cadmium zinc telluride digital detectors rather than scintillation crystals and photomultiplier tubes (SCAN 6/11/97). Since then, the company has been building a 14,000-square-foot semiconductor fab to manufacture the cameras, according to Karen Klause, president and CEO. Construction of the fab should be finished soon, and 2020 TC Imagers should be shipping some time this year, she said.
At next months Society of Nuclear Medicine meeting in Toronto, Digirad plans to display its latest work on conducting SPECT imaging with its camera using a rotating chair. Because 2020 TC Imagers detector is not housed in a rotating gantry, patients are seated and rotated around the head. Digirad will display cardiac SPECT images collected with the technique, Klause said.
Digirad will also present three papers, the first for the company at a medical conference. One of the papers covers work conducted on scintimammography with Dr. Iraj Khalkhali of Harbor-UCLA Medical Center in Torrance, CA.
Until Digirad is able to start shipping, the company will continue to take orders, which are coming in at a rapid clip from hospitals interested in the firms novel technology, Klause said
We have a long lead time right now (for deliveries) due to the backlog, Klause said. Demand has been much greater than we expected.
Emerging Perspectives on PSMA PET Radiotracers: An Interview with Kenneth J. Pienta, MD
April 24th 2024In a recent interview, Kenneth J. Pienta, M.D., discussed the impact of piflufolastat F18, current directions in research with other PSMA-targeted radiotracers and future possibilities for the role of PSMA PET in the imaging paradigm for prostate cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.